Diabetes-related lower limb amputations jump nearly 20%
The number of diabetes related lower-limb amputations has leapt nearly 20% since 2013, according to a new report by Diabetes UK.
Read MoreThe number of diabetes related lower-limb amputations has leapt nearly 20% since 2013, according to a new report by Diabetes UK.
Read MoreNovartis has pulled back its application to market canakinumab for the prevention of serious events such as stroke, myocardial infarction (MI) or death in patients who have had an MI in Europe.
Read MoreThe European Medicines Agency’s human medicines committee (CHMP) has put forward seven medicines for approval in the region.
Read MoreInnovate UK has awarded PredictImmune a £100,000 grant to apply its biomarker-based technology towards the prediction of drug response in IBD.
Read MoreA Scottish government Health and Social care report has shown that the gap in health outcomes between the most and least deprived areas is Scotland persist to be ‘significant’, despite welcome improvements in some areas.
Read More




PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
